Stevanato Group S.p.A. (NYSE:STVN) Sees Significant Drop in Short Interest

Stevanato Group S.p.A. (NYSE:STVN) saw a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 1,539,632 shares, a drop of 19.9% from the February 12th total of 1,922,035 shares. Approximately 0.5% of the company’s shares are short sold. Based on an average daily volume of 625,122 shares, the days-to-cover ratio is currently 2.5 days. Based on an average daily volume of 625,122 shares, the days-to-cover ratio is currently 2.5 days. Approximately 0.5% of the company’s shares are short sold.

Stevanato Group Stock Up 0.6%

Shares of NYSE STVN traded up €0.10 during mid-day trading on Tuesday, reaching €15.45. 286,200 shares of the company’s stock traded hands, compared to its average volume of 703,794. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.76 and a quick ratio of 1.26. The business has a 50-day simple moving average of €16.82 and a 200 day simple moving average of €21.28. The stock has a market cap of $4.68 billion, a P/E ratio of 26.63, a PEG ratio of 1.37 and a beta of 0.57. Stevanato Group has a 1-year low of €13.91 and a 1-year high of €28.00.

Institutional Trading of Stevanato Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. PNC Financial Services Group Inc. boosted its position in shares of Stevanato Group by 7.7% during the second quarter. PNC Financial Services Group Inc. now owns 9,893 shares of the company’s stock valued at $242,000 after buying an additional 711 shares during the last quarter. First Bank & Trust raised its position in Stevanato Group by 5.6% in the 4th quarter. First Bank & Trust now owns 17,109 shares of the company’s stock valued at $344,000 after buying an additional 904 shares during the last quarter. GW&K Investment Management LLC lifted its stake in Stevanato Group by 76.2% during the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after acquiring an additional 1,055 shares in the last quarter. Pathstone Holdings LLC lifted its stake in Stevanato Group by 1.5% during the 3rd quarter. Pathstone Holdings LLC now owns 71,178 shares of the company’s stock valued at $1,833,000 after acquiring an additional 1,067 shares in the last quarter. Finally, Van Berkom & Associates Inc. boosted its holdings in Stevanato Group by 50.6% during the 3rd quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after acquiring an additional 1,215 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on STVN shares. Citigroup cut their price objective on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a report on Thursday, March 5th. Jefferies Financial Group set a $17.50 price target on Stevanato Group in a research note on Tuesday, February 10th. Weiss Ratings lowered Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 11th. Wall Street Zen cut Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Finally, Morgan Stanley dropped their price objective on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, March 6th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.